Fig. 3From: P38 MAPK expression and activation predicts failure of response to CHOP in patients with Diffuse Large B-Cell LymphomaImpact of p38 and p-p38 expressions on the prognosis of DLBCL patients. a Event-free survival (EFS) curves for DLBCL patients treated with CHOP according to p38 MAPK expression. The curves correspond to positive (n = 66) versus negative (n = 14) p38 MAPK expression b. Overall survival (OS) curves for DLBCL patients treated with CHOP according to p38 MAPK expression. c EFS curves according to the p-p38+ MAPK expression (n = 24) versus p-p38-MAPK (n = 56) d. Overall survival (OS) curve for DLBCL patients treated with CHOP according to positive p-p38 MAPK expression (n = 24) versus p-p38− MAPK expression (n = 56)Back to article page